Clinical Trial Update: Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial [Phase 4]

View source ↗

Summary

The STAR trial is a Phase 4 study evaluating steroid treatment for severe acute respiratory infection in patients with hypoxemia; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome

Drugs mentioned

• Steroid therapy (Corticosteroid)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hypoxemia, Severe Acute Respiratory Syndrome | Phase 4 | Status: NOT_YET_RECRUITING